New inflammatory markers for prediction of non-dipper blood pressure pattern in patients with essential hypertension: Serum YKL-40/Chitinase 3-like protein 1 levels and echocardiographic epicardial adipose tissue thickness

References

• Nillar-Craig NW, Bishop CV, Raftery EB. Circadian variation of blood pressure. Lancet 1978;1:795–7
   PubMed Web of Science ®Google Scholar
• Verdecchia P, Schillaci G, Guerrieri M, et al. Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension. Circulation 1990;81:528–36
   PubMed Web of Science ®Google Scholar
• Izzedine H, Launay-Vacher V, D eray G. Abnormal blood pressure circadian rhythm: a target organ damage? Int J Cardiol 2006;107:343–9
   PubMed Web of Science ®Google Scholar
• Johansen JS. Studies on serum YKL-40 as a biomarker in diseases with inflammation, tissue remodelling, fibroses and cancer. Dan Med Bull 2006;53:172–209
   PubMed Web of Science ®Google Scholar
• Rehli M, Krause SW, Andreesen R. Molecular characterization of the gene for human cartilage gp-39 (CHI3L1), a member of the chitinase protein family and marker for late stages of macrophage differentiation. Genomics 1997;43:221–5
   PubMed Web of Science ®Google Scholar
• Tang H, Fang Z, Sun Y, et al. YKL-40 in asthmatic patients, and its correlations with exacerbation, eosinophils and immunoglobulin E. Eur Respir J 2010;35:757–60
   PubMed Web of Science ®Google Scholar
• Rathcke CN, Vestergaard H. YKL-40, a new inflammatory marker with relation to insulin resistance and with a role in endothelial dysfunction and atherosclerosis. Inflamm Res 2006;55:221–7
   PubMed Web of Science ®Google Scholar
• Kucur M, Isman FK, Karadag B, et al. Serum YKL-40 levels in patients with coronary artery disease. Coron Artery Dis 2007;18:391–6
   PubMed Web of Science ®Google Scholar
• Kjaergaard AD, Bojesen SE, Johansen JS, Nordestgaard BG. Elevated plasma YKL-40 levels and ischemic stroke in the general population. Ann Neurol 2010;68:672–80
   PubMed Web of Science ®Google Scholar
• Henningsen KM, Therkelsen SK, Johansen JS, et al. Plasma YKL-40, a new biomarker for atrial fibrillation? Europace 2009;11:1032–6
   PubMed Web of Science ®Google Scholar
• Ma WH, Wang XL, Du YM, et al. Association between human cartilage glycoprotein 39 (YKL-40) and arterial stiffness in essential hypertension. BMC Cardiovasc Disord 2012;12:35
   PubMed Web of Science ®Google Scholar
• Ridker PM, Chasman DI, Rose L, et al. Plasma levels of the proinflammatory chitin-binding glycoprotein YKL-40, variation in the chitinase 3-like 1 gene (CHI3L1), and incident cardiovascular events. J Am Heart Assoc 2014;3:e000897
   Web of Science ®Google Scholar
• Diao YY, Lü QZ, Yang CS, Wei D. Association between serum YKL-40 levels and endothelial function in hypertensive patients. Zhonghua Xin Xue Guan Bing Za Zhi 2013;41:121–5
   PubMedGoogle Scholar
• Iacobellis G, Willens HJ. Echocardiographic epicardial fat: a review of research and clinical applications. J Am Soc Echocardiogr 2009;22:1311–19
   PubMed Web of Science ®Google Scholar
• Comert N, Yucel O, Ege MR, et al. Echocardiographic epicardial adipose tissue predicts subclinical atherosclerosis: epicardial adipose tissue and atherosclerosis. Angiology 2012;63:586–90
   PubMed Web of Science ®Google Scholar
• Turak O, Özcan F, Canpolat U, et al. Increased echocardiographic epicardial fat thickness and high-sensitivity CRP level indicate diastolic dysfunction in patients with newly diagnosed essential hypertension. Blood Press Monit 2013;18:259–64
   PubMed Web of Science ®Google Scholar
• Erdogan T, Canga A, Kocaman SA, et al. Increased epicardial adipose tissue in patients with slow coronary flow phenomenon. Kardiol Pol 2012;70:903–9
   PubMed Web of Science ®Google Scholar
• James PA, Oparil S, Carter BL, et al. Evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 2014;311:507–20
   PubMed Web of Science ®Google Scholar
• Ohkubo T, Hozawa A, Yamaguchi J, et al. Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study. J Hypertens 2002;20:2183–9
   PubMed Web of Science ®Google Scholar
• Verdecchia P, Schillaci G, Reboldi G, et al. Different prognostic impact of 24-hour mean blood pressure and pulse pressure on stroke and coronary artery disease in essential hypertension. Circulation 2001;103:2579–84
   PubMed Web of Science ®Google Scholar
• Sherwood A, Routledge FS, Wohlgemuth WK, et al. Blood pressure dipping: ethnicity, sleep quality, and sympathetic nervous system activity. Am J Hypertens 2011;24:982–8
   PubMed Web of Science ®Google Scholar
• Mann S, Altman DG, Raftery EB, Bannister R. Circadian variation of blood pressure in autonomic failure. Circulation 1983;68:477–83
   PubMed Web of Science ®Google Scholar
• Kaya MG, Yarlioglues M, Gunebakmaz O, et al. Platelet activation and inflammatory response in patients with non-dipper hypertension. Atherosclerosis 2010;209:278–82
   PubMed Web of Science ®Google Scholar
• Ermis N, Yagmur J, Acikgoz N, et al. Serum gamma-glutamyl transferase (GGT) levels and inflammatory activity in patients with non-dipper hypertension. Clin Exp Hypertens 2012;34:311–15
   PubMed Web of Science ®Google Scholar
• Ozcan F, Turak O, Durak A, et al. Red cell distribution width and inflammation in patients with non-dipper hypertension. Blood Press 2013;22:80–5
   PubMed Web of Science ®Google Scholar
• Meric M, Soylu K, Avci B, et al. Evaluation of plasma chemerin levels in patients with non-dipper blood pressure patterns. Med Sci Monit 2014;20:698–705
   PubMed Web of Science ®Google Scholar
• Sunbul M, Gerin F, Durmus E, et al. Neutrophil to lymphocyte and platelet to lymphocyte ratio in patients with dipper versus non-dipper hypertension. Clin Exp Hypertens 2014;36:217–21
   PubMed Web of Science ®Google Scholar
• Rathcke CN, Vestergaard H. YKL-40-an emerging biomarker in cardiovascular disease and diabetes. Cardiovasc Diabetol 2009;23:8–61
   Google Scholar
• Giles TD. Assessment of global risk: a foundation for a new, better definition of hypertension. J Clin Hypertens 2006;8:5–14
   Google Scholar
• Turkyilmaz AK, Devrimsel G, Kirbas A, et al. Relationship between pulse wave velocity and serum YKL-40 level in patients with early rheumatoid arthritis. Rheumatol Int 2013;33:2751–6
   PubMed Web of Science ®Google Scholar
• Sakamoto F, Katakami N, Kaneto H, et al. Association of serum YKL-40 levels with urinary albumin excretion rate in young Japanese patients with type 1 diabetes mellitus. Endocr J 2013;60:73–9
   PubMed Web of Science ®Google Scholar
• Kocyigit I, Gungor O, Dogan E, et al. The serum YKL-40 level is associated with vascular injury and predicts proteinuria in nephrotic syndrome patients. J Atheroscler Thromb 2014 . [Epub ahead of print]
   Web of Science ®Google Scholar
• Jafari B, Elias JA, Mohsenin V. Increased plasma YKL-40/Chitinase-3-Like-Protein-1 is associated with endothelial dysfunction in obstructive sleep apnea. PLoS One 2014;9:e98629
   PubMed Web of Science ®Google Scholar
• Gastaldelli A, Basta G. Ectopic fat and cardiovascular disease: What is the link? Nutr Metab Cardiovasc Dis 2010;20:481–90
   PubMed Web of Science ®Google Scholar
• Sironi AM, Gastaldelli A, Mari A, et al. Visceral fat in hypertension: influence on insulin resistance and beta-cell function. Hypertension 2004;44:127–33
   PubMed Web of Science ®Google Scholar
• Sengul C, Cevik C, Ozveren O, et al. Epicardial fat thickness is associated with non-dipper blood pressure pattern in patients with essential hypertension. Clin Exp Hypertens 2012;34:165–70
   PubMed Web of Science ®Google Scholar
• Ertas F, Kaya H, Acet H, et al. Increased echocardiographic epicardial fat thickness is related to impaired diurnal blood pressure profiles. Blood Press 2012;21:202–8
   PubMed Web of Science ®Google Scholar
• Clearfield MB. C-reactive protein: a new risk assessment tool for cardiovascular disease. J Am Osteopath Assoc 2005;105:409–16
   PubMedGoogle Scholar
• Tsioufis C, Syrseloudis D, Dimitriadis K, et al. Disturbed circadian blood pressure rhythm and C-reactive protein in essential hypertension. J Hum Hypertens 2008;22:501–8
   PubMed Web of Science ®Google Scholar
• Erdogan D, Icli A, Aksoy F, et al. Relationships of different blood pressure categories to indices of inflammation and platelet activity in sustained hypertensive patients with uncontrolled office blood pressure. Chronobiol Int 2013;30:973–80
   PubMed Web of Science ®Google Scholar